+
+

Related Products

  • Qualio
    858 Ratings
    Visit Website
  • StackAI
    53 Ratings
    Visit Website
  • FrameworkLTC
    48 Ratings
    Visit Website
  • MaintainX
    2,492 Ratings
    Visit Website
  • Process Street
    1,112 Ratings
    Visit Website
  • Interfacing Integrated Management System (IMS)
    66 Ratings
    Visit Website
  • HSI Donesafe
    155 Ratings
    Visit Website
  • RegDesk
    19 Ratings
    Visit Website
  • Tremendous
    1,795 Ratings
    Visit Website
  • Parasoft
    143 Ratings
    Visit Website

About

DrugCard is an AI-powered pharmacovigilance platform that helps pharmaceutical companies, CROs, and drug safety teams automate key PV workflows. The platform supports global and local literature monitoring, regulatory intelligence, and adverse event management, helping teams reduce manual screening, identify relevant safety information faster, and maintain audit-ready processes. DrugCard combines AI-driven article pre-assessment, summaries, translations, keyword highlighting, notifications, reporting, audit trails, and case management tools in one connected system. With coverage of 121+ countries, 2,200+ local medical sources, and 100+ languages, DrugCard is designed for MAHs, QPPVs, LQPPVs, regulatory teams, and PV professionals who need scalable, transparent, and compliant automation while keeping human experts in control of final decisions.

About

Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Pharmacovigilance teams, Marketing Authorization Holders, CROs, QPPVs and LQPPVs, Drug Safety Officers, Regulatory Affairs teams, Pharmaceutical and biotech companies

Audience

Recursion is ideal for researchers, pharmaceutical partners, investors, and healthcare stakeholders interested in AI-driven drug discovery and next-generation therapeutic development

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

individual
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

DrugCard
Founded: 2021
Estonia
drug-card.io

Company Information

Recursion
United States
www.recursion.com

Alternatives

Alternatives

PharmaPendium

PharmaPendium

Elsevier

Categories

Categories

Integrations

No info available.

Integrations

No info available.
Claim DrugCard and update features and information
Claim DrugCard and update features and information
Claim Recursion and update features and information
Claim Recursion and update features and information